Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

SPRY

ARS Pharmaceuticals Inc

May 22 • 04:00PM ET

7.94

-0.29 -3.52 %

Healthcare • Biotechnology • USA • Small • NASD

Peers: COGT ARQT TRVI CABA AUPH

| Held by: XBI VTI IWM VXF IWO IBB SCHA VTWO SMLF VHT

Scroll to Statements

Index	RUT	P/E	-	EPS (ttm)	-2.00	Insider Own	36.94%	Shs Outstand	99.30M	Perf Week	6.94%
Market Cap	788.47M	Forward P/E	-	EPS next Y	-0.95	Insider Trans	0.00%	Shs Float	62.67M	Perf Month	-4.34%
Enterprise Value	684.61M	PEG	-	EPS next Q	-0.48	Inst Own	74.29%	Short Float	41.79%	Perf Quarter	-13.79%
Income	-197.98M	P/S	7.97	EPS this Y	-0.57%	Inst Trans	-0.48%	Short Ratio	16.37	Perf Half Y	11.99%
Sales	98.99M	P/B	12.86	EPS next Y	45.60%	ROA	-64.39%	Short Interest	26.19M	Perf YTD	-31.85%
Book/sh	0.62	P/C	3.92	EPS next 5Y	-	ROE	-136.40%	52W High	18.90 -57.99%	Perf Year	-45.32%
Cash/sh	2.02	P/FCF	-	EPS past 3/5Y	-26.04% -12.85%	ROIC	-125.44%	52W Low	6.66 19.22%	Perf 3Y	-12.65%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	300.09% -	Gross Margin	74.12%	Volatility	7.41% 6.61%	Perf 5Y	-71.80%
Dividend TTM	-	EV/Sales	6.92	EPS Y/Y TTM	-1130.30%	Oper. Margin	-204.49%	ATR (14)	0.54	Perf 10Y	-
Dividend Ex-Date	-	Quick Ratio	4.77	Sales Y/Y TTM	1.92%	Profit Margin	-200.00%	RSI (14)	46.94	Recom	1.00
Dividend Gr. 3/5Y	- -	Current Ratio	4.94	EPS Q/Q	-76.39%	SMA20	-3.45%	Beta	0.91	Target Price	25.60
Payout	-	Debt/Eq	1.58	Sales Q/Q	184.47%	SMA50	-3.11%	Rel Volume	1.55	Prev Close	8.23
Employees	163	LT Debt/Eq	1.57	Earnings	May 15 BMO	SMA200	-19.44%	Avg Volume	1.60M	Price	7.94
IPO	Dec 04, 2020	Option/Short	Yes / Yes	EPS/Sales Surpr.	-18.22% 2.17%	Trades		Volume	2,482,298	Change	-3.52%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)